Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Mundipharma International
Mundipharma International
Activities:
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy
The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients
Teva UK and Closed Loop Medicine partner to advance personalised medicine development
SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Henkel facilities receive EXCiPACT certificate as suppliers of pharmaceutical excipients
The certification means Henkel meets EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP)
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Ingredients
Helsinn brings cancer pain management option to China
With the help of Mundipharma China Pharmaceutical, ALOXI IV will be used for the prevention of chemotherapy-induced nausea and vomiting (CINV) in China
Media
Grunenthal and Mundipharma enter commercial partnership in China
Grünenthal and Mundipharma announced they have entered into a License and Distribution Agreement
Media
Mundipharma and CellAct announce deal for development of smart chemo
CellAct has provided the Mundipharma network, of independent associated companies, the worldwide development, commercialisation and manufacturing rights to CAP7.1
Distribution
Mundipharma partners with Munir Sukhtian Group to strengthen its consumer healthcare business
Partnership to increases access to the HiGeen range of products for millions of people across the Middle East and Africa region
Research & Development
Mundipharma Laboratories and Purdue Pharma enter global partnership with Laboratorios Esteve
To drive innovation in pain management
Subscribe now